Bridgeway Capital Management’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
VPM
RP
VCM
Bridgeway Capital Management's ACLS Position: Q1 2026 in Review
Bridgeway Capital Management sold out of Axcelis (ACLS) in Q1 2026, closing a stake of 36,000 shares — an estimated $2.89M sold.
Bridgeway Capital Management first reported a position in ACLS in Q2 2013 and held it in 22 quarters. The position peaked at $3.03M in Q3 2025. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.
- Bridgeway Capital Management reported no remaining Axcelis position as of Q1 2026 after selling out during the quarter.
- Bridgeway Capital Management sold 36,000 Axcelis shares in Q1 2026, an estimated $2.89M.
- Bridgeway Capital Management first reported a position in Axcelis in Q2 2013 and held it in 22 quarters.
- Bridgeway Capital Management's Axcelis position peaked at $3.03M in Q3 2025.
- 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.
Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.